Literature DB >> 2487154

Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system.

J A Biegel1, L B Rorke, R J Packer, L N Sutton, L Schut, K Bonner, B S Emanuel.   

Abstract

We have prepared karyotypes from 22 primitive neuroectodermal tumors (PNETs) from pediatric patients ranging in age from 10 months to 16 years. Twenty-one cases were newly diagnosed, primary, posterior fossa tumors. One case was a recurrent tumor in a patient previously treated with radiation. Cytogenetic results were obtained from direct preparations and/or short-term (1-10 day) culture. Three tumors had apparently normal karyotypes. Nineteen tumors demonstrated numerical and/or structural abnormalities. The most frequent structural chromosomal changes were deletions and nonreciprocal translocations. Four tumors contained double minutes. Several chromosomes appear to be nonrandomly involved in PNETs. These include chromosomes 5, 6, 11, 16, 17, and a sex chromosome. The most consistent change, however, was an i(17q), present in one-third (8/22) of the cases. Strikingly, in three of these eight tumors, the i(17q) was the only structural abnormality observed. An i(17q) is not specific for pediatric PNETs, as it is also seen in leukemias and other solid tumors. However, in PNETs it may be a primary change related to tumor development and/or progression. Clinically, there was no correlation of the cytogenetic findings with histologic features of the tumors, size of the tumor, extent of metastasis, or surgical resection.

Entities:  

Mesh:

Year:  1989        PMID: 2487154     DOI: 10.1002/gcc.2870010206

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  25 in total

1.  Primary peripheral primitive neuroectodermal tumors of the spinal cord: report of two cases and review of the literature.

Authors:  R Perry; I Gonzales; J Finlay; S Zacharoulis
Journal:  J Neurooncol       Date:  2007-01-03       Impact factor: 4.130

2.  Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland.

Authors:  D L Baker; W M Molenaar; J Q Trojanowski; A E Evans; A H Ross; L B Rorke; R J Packer; V M Lee; D Pleasure
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

3.  Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors.

Authors:  Jacquelyn J Roth; Mariarita Santi; Lucy B Rorke-Adams; Brian N Harding; Tracy M Busse; Laura S Tooke; Jaclyn A Biegel
Journal:  Cancer Genet       Date:  2014-03-15

4.  Imaging findings of adrenal primitive neuroectodermal tumors: a series of seven cases.

Authors:  Y Zhang; P Cai; M Chen; X Yi; L Li; D Xiao; W Liu; W Li; Y Li
Journal:  Clin Transl Oncol       Date:  2016-11-23       Impact factor: 3.405

Review 5.  Molecular analysis of pediatric brain tumors.

Authors:  Jaclyn A Biegel; Ian F Pollack
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 6.  Medulloblastoma: molecular genetics and animal models.

Authors:  Corey Raffel
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

Review 7.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

8.  The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.

Authors:  Hirokatsu Osawa; Christian A Smith; Young Shin Ra; Paul Kongkham; James T Rutka
Journal:  Neuro Oncol       Date:  2008-12-16       Impact factor: 12.300

9.  Prognostic implications of chromosome 17p deletions in human medulloblastomas.

Authors:  S K Batra; R E McLendon; J S Koo; S Castelino-Prabhu; H E Fuchs; J P Krischer; H S Friedman; D D Bigner; S H Bigner
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours.

Authors:  C M Phelan; L Liu; M H Ruttledge; K Müntzning; P A Ridderheim; V P Collins
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.